Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
3(16%)
Results Posted
38%(5 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_2
3
16%
Ph phase_1
1
5%
Ph phase_3
4
21%
Ph not_applicable
9
47%
Ph phase_4
2
11%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
3(15.8%)
Phase 3Large-scale testing
4(21.1%)
Phase 4Post-market surveillance
2(10.5%)
N/ANon-phased studies
9(47.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.7%

13 of 15 finished

Non-Completion Rate

13.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

19

all time

Status Distribution
Active(3)
Completed(13)
Terminated(2)
Other(1)

Detailed Status

Completed13
Recruiting3
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
3
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.3%)
Phase 23 (15.8%)
Phase 34 (21.1%)
Phase 42 (10.5%)
N/A9 (47.4%)

Trials by Status

unknown15%
terminated211%
recruiting316%
completed1368%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT07345585Not Applicable

Probiotics for Autism Spectrum Disorders: a Randomized Controlled Trial (The PASD Study)

Recruiting
NCT05517928Not Applicable

A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

Recruiting
NCT07296718Phase 4

Single Vs Multi-strain Probiotics for Preterm Neonates

Completed
NCT05178069Phase 2

LGG Supplementation in Patients With AUD and ALD

Recruiting
NCT04399252Not Applicable

Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19

Completed
NCT01922895Not Applicable

Novel Therapies in Moderately Severe Acute Alcoholic Hepatitis

Terminated
NCT02110732Not Applicable

Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil

Completed
NCT02144701Not Applicable

Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Completed
NCT02748317Phase 2

Impact of Probiotics on Urinary Symptoms in Spinal Cord Injury SCI and SB

Completed
NCT03863418Not Applicable

Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis

Unknown
NCT01551186Phase 4

The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria

Completed
NCT00946283Not Applicable

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Terminated
NCT02642289Not Applicable

Probiotics: Clinical Intervention Trial in Patients With Fibromyalgia

Completed
NCT01870544Phase 1

Does Weight Loss Surgery and Probiotic Supplementation Lead to a "Lean" Gut Microbiota?

Completed
NCT01956916Phase 3

Probiotics in Cystic Fibrosis

Completed
NCT02558192Phase 3

Administration of a Lactobacillus GG and Vitamins Containing Mixture is Effective in Preventing Nosocomial Infection in Children

Completed
NCT00325273Phase 3

Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal Period

Completed
NCT01961661Phase 3

Probiotics on Intestinal Inflammation in Cystic Fibrosis

Completed
NCT00445120Phase 2

Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment

Completed

All 19 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
19